^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    FZ-AD004

    i
    Other names: FZ-AD004, Trop2-BB05 ADC, F0040
    Associations

    News

    Trials
    Company:
    Shanghai Fudan-Zhangjiang
    Drug class:
    Topoisomerase I inhibitor, TROP-2-targeted antibody-drug conjugate
    Related drugs:
    Associations

    News

    Trials
    7ms
    A Study of FZ-AD004 in Patients With Advanced Solid Tumors (clinicaltrials.gov)
    P1, N=121, Recruiting, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | Not yet recruiting --> Recruiting
    Enrollment open • Metastases
    |
    FZ-AD004
    over1year
    A Study of FZ-AD004 in Patients With Advanced Solid Tumors (clinicaltrials.gov)
    P1, N=121, Not yet recruiting, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
    New P1 trial • Metastases
    |
    FZ-AD004